NextCure Inc

NextCure Inc. is a clinical-stage biopharmaceutical company headquartered in Beltsville, Maryland. The company employs a small team of 3 individuals. NextCure is dedicated to developing innovative immunomedicines for the treatment of cancer and other immune-related diseases. NextCure's core focus is on restoring normal immune function through a holistic approach. Rather than targeting specific immune cell types, the company investigates biological pathways, cellular interactions, and their roles in immune responses. Their proprietary FIND-IO platform allows them to study various immune cells, identify targets, and understand the functional impact of these targets in developing effective immunomedicines. NextCure's mission is to provide treatment options for patients who haven't responded to existing therapies, those whose cancer has progressed despite treatment, and those with cancer types currently lacking adequate treatment options. NextCure can be reached through their website at nextcure.com.